The Hong Kong Polytechnic University Shenzhen Research Institute (SZRI) and Shenzhen Nanshan Hospital have collaborated to organize a seminar that aims to delve into the new frontier of immunotherapy, with a specific focus on its clinical application.
The conference centered around discussions in four areas: precise targeted disease diagnosis and treatment, immune cell regulation for disease treatment, cell metabolism research in immunotherapy, and nanomedicine. Interactive sharing and engaging discussion also took place with the guests.
Prof. Dong Cheng, Associate Vice President (Mainland Research Advancement) of The Hong Kong Polytechnic University (PolyU) and Director of SZRI stated that PolyU was committed to cultivating top-tier talent and conducting both fundamental and applied research, as well as promoting world-class innovation and entrepreneurship. The stem cell engineering and immunotherapy research platform being developed by SZRI would become the twelfth research institute under PolyU Academy for Interdisciplinary Research. It would also be the first interdisciplinary research platform established outside of the University's main campus, reflecting PolyU's commitment to integrating local medical research and clinical practice, and accelerating the transfer and application of research results.
